Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

synektik s.a., , poľsko - fluórmetylcholín (18f) - 88 - radiopharmaca

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

biont, a.s., slovensko - fluórmetylcholín (18f) - 88 - radiopharmaca

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

curium austria gmbh, rakúsko - fluórmetylcholín (18f) - 88 - radiopharmaca

Európska únia - slovenčina - EMA (European Medicines Agency)

curium pet france - piflufolastat (18f) - prostatické nádory - diagnostické rádiofarmaká - tento liek je určený len na diagnostické účely. pylclari is indicated for the detection of prostate-specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high-risk pca prior to initial curative therapy,to localize recurrence of pca in patients with a suspected recurrence based on increasing serum prostate-specific antigen (psa) levels after primary treatment with curative intent. pylclari is indicated for use with positron emission tomography (pet).